With regard to allograft survival, we detected no GNB3 genotype-dependent differences in the generation of de novo anti-HLA DSAs, the occurrence of different types of rejection, or the occurrence of bacterial or viral infection as important posttransplant complications (Table 2). This evidence concerns the gene GNB3 and viral infectious disease.